Position in AZN
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$796,593
-$31,927 QoQ
Shares Held
4,201
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#725
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OAKWORTH CAPITAL, INC. holds $21,742,030 across 13 Drug Manufacturers - General names. AZN ranks #5 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,682 | $5,615,730 | |
| 2 | MRK |
Merck & Co., Inc.
|
37,177 | $4,777,244 | |
| 3 | JNJ |
Johnson & Johnson
|
18,417 | $4,677,363 | |
| 4 | ABBV |
AbbVie Inc.
|
12,650 | $3,183,244 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
4,201 | $796,593 | |
| 6 | AMGN |
Amgen Inc
|
2,008 | $727,136 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
10,513 | $605,758 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,689 | $592,407 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $796,593 | 4,201 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $828,520 | 4,201 | Shares | Sole | 2026-04-24 | |
| No filing history on record for this holder in this stock. | ||||||